DUNAD THERAPEUTICS LTD.Active
Key figures
DUNAD THERAPEUTICS LTD. does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Turnover | 3,754,774 | — | — | — |
| Profit for the year | -673,575 | -11,488,995 | -12,774,083 | -11,729,168 |
| Cash at bank and in hand | 25,254,899 | 11,623,839 | 7,996,627 | 287,459 |
| Total assets | — | 15,509,747 | 9,560,917 | 522,547 |
| Total liabilities | — | — | — | 2,770,908 |
| Net assets / total equity | 22,320,871 | 11,250,812 | 8,690,099 | -2,248,361 |
| Average number of employees | 11 | 13 | 0 | 7 |
| Average pay (per year) | — | 159,648 | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Group continued to be that of research and experimental development on biotechnology.
As described in the company's latest filed accounts.
Summary: DUNAD THERAPEUTICS LTD.
Company
DUNAD THERAPEUTICS LTD. is a private limited company registered with Companies House under company number 12544797. It was incorporated on 2 Apr 2020. Its status is active. The registered office is in Cambridge (CB22). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files group accounts. Loss for the year was £11,729,168. Net assets were −£2,248,361, down 125.9% on the previous year. Cash at bank and in hand was £287,459. Total assets were £522,547 and total liabilities £2,770,908. The company had an average of 7 employees. Figures are available for 4 financial years (2022–2025).
Control and charges
1 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 15 Apr 2027.